Child & Family Studies Program, Baylor University, Waco, Texas, USA.
Baylor, Scott & White Cancer Center, Temple, Texas, USA.
J Sex Med. 2021 Apr;18(4):737-742. doi: 10.1016/j.jsxm.2021.01.171. Epub 2021 Feb 6.
As tumor treatment has advanced, patients are surviving and returning to productive lives. Quality of life (QoL) has become a significant consideration in the care of survivors. The 2005 Institute of Medicine Cancer Survivorship Care Planning requires the inclusion of information on the possible effects of cancer on marital/partner relationship and sexual functioning, among other factors related to QoL.
The purpose of this study is to explore the quality of life and the rates and types of sexual dysfunction among brain tumor patients.
Patients were recruited from a neuro-oncology practice and given a QoL questionnaire (FACT-Br). Women were given the Female Sexual Function Index (FSFI). Men were given scales to assess premature ejaculation (PE), erectile dysfunction (ED), and Peyronie's disease. In addition, information about the site and type of tumor and treatment (surgery, radiation, chemotherapy) was collected. Descriptive statistics, as well as T-tests and ANOVAs, were used to analyze the data.
Study outcomes were obtained utilizing clinical cutoff scores for the sexual function questionnaires.
Data were collected on 50 patients. The most common form of brain tumor in this sample was glioblastoma. The frontal lobe was the most common location of tumors. There was significantly more sexual dysfunction than previously reported, with 66% of the sexually active women meeting the criteria for total FSFI. Of the men who were sexually active, 60% reported some ED, and 80% reported PE.
The current findings contribute to supporting the assertion that it is important for physicians to discuss with their cancer patients the issues related to sexual function.
STRENGTHS & LIMITATIONS: A primary strength of this study is the utilization of validated assessments of sexual function. The primary limitation is the sample size, particularly for men.
Our capacity to address the sexual function concerns of patients is dependent on our understanding of the types of difficulties encountered. This study contributes information about sexual function, a major contributor to QoL, in patients with brain tumor diagnosis and treatment. Boccia ML, Anyanda EI, Fonkem E. A Preliminary Report on Quality of Life and Sexual Function in Brain Tumor Patients. J Sex Med 2021;18:737-742.
随着肿瘤治疗的进步,患者得以存活并重返正常生活。生活质量(QoL)已成为肿瘤患者治疗的重要考虑因素。2005 年美国医学研究所的癌症生存者护理计划要求纳入有关癌症对婚姻/伴侣关系和性功能等与 QoL 相关因素的潜在影响的信息。
本研究旨在探讨脑肿瘤患者的生活质量以及性功能障碍的发生率和类型。
患者从神经肿瘤学门诊招募,并接受生活质量问卷(FACT-Br)调查。女性接受女性性功能指数(FSFI)调查。男性则接受评估早泄(PE)、勃起功能障碍(ED)和佩罗尼氏病的量表。此外,还收集了肿瘤部位和类型以及治疗(手术、放疗、化疗)的相关信息。采用描述性统计、T 检验和方差分析对数据进行分析。
研究结果采用性功能问卷的临床临界值得分来评估。
本研究结果表明,医生与癌症患者讨论与性功能相关的问题非常重要。
本研究的主要优势在于使用了经过验证的性功能评估方法。主要局限性在于样本量较小,尤其是男性。
我们能否解决患者的性功能问题取决于我们对所遇到问题类型的理解。本研究为脑肿瘤诊断和治疗患者的生活质量的主要影响因素——性功能提供了相关信息。